Global PCR Technologies Market Assessment, By Product [Instruments, Reagents, Consumables, Software and Services, Others], By Technology [Conventional PCR, qPCR (Real-Time PCR), dPCR (Digital PCR), Other PCR Technologies], By Application [Research Applications, Diagnostics Applications, Others], By End-user [Hospital, Diagnostic Centre, Pharmaceutical and Biotechnology Companies, Clinical Research Organizations, Academia Laboratories], By Region, Opportunities and Forecast, 2017-2031F
Global PCR technologies market size was valued at USD 15.05 billion in 2023, and is expected to reach USD 29.75 billion in 2031, with a CAGR of 8.89% for the forecast period between 2024 and 2031F.
Home>Industry Reports>Global PCR Technologies Market Assessment, Opportunities and Forecast, 2017-2031F
Global PCR technologies market size was valued at USD 15.05 billion in 2023, and is expected to reach USD 29.75 billion in 2031, with a CAGR of 8.89% for the forecast period between 2024 and 2031F. The Polymerase Chain Reaction technologies market is a rapidly growing field in molecular biology, life sciences, and biotechnology. The PCR technologies market is expanding owing to the increasing application of PCR in clinical disease diagnosis and genetic and molecular testing. The prevalence of infectious diseases like hepatitis, influenza, HIV infection, and COVID-19 infection which require PCR techniques for diagnosis, have been on the rise in recent years, driving demand in the global PCR technologies market.
Advancements in PCR techniques, such as digital PCR (dPCR) and real-time PCR (qPCR), offer benefits like low reagent consumption, automation of workflow, and greater reproducibility and precision, which are encouraging the adoption of PCR technologies, further fueling the market growth. Growing market penetration in emerging countries and attractive opportunities in the PCR technologies market have led to increased funding and investments. With increasing interest from investors and market players, the demand and supply both are significantly increasing. Additionally, government support for research and development is further encouraging market development. However, the high cost of PCR instruments, technical limitations of PCR technology, and lack of skilled professionals to perform the protocols are major restraints for the global PCR technologies market.
In November 2023, QIAGEN announced the launch of three new kits (QIAcuity Mycoplasma Quant Kit, QIAcuity OneStep Advanced EG Kit, and QIAcuity Mericon Food Testing Kits) for using them with its QIAcuity systems. The launch has a part where major new software updates are designed to expand the portfolio of applications for the use of dPCR technology in areas like cell and gene therapies, quantification of DNA and RNA, as well as food and pharmaceutical safety.
Increasing Prevalence of Infectious and Genetic Diseases
The increasing prevalence of infectious diseases like hepatitis, influenza, HIV is a significant driver for the PCR technologies market. The rise in infectious diseases and genetic diseases has led to a growing demand for PCR technologies, as they play a crucial role in the diagnosis and monitoring of these diseases. PCR is widely used in the detection of various infectious agents, including viruses, bacteria, and fungi, making it an indispensable tool in infectious disease management. PCR technologies are also used in the detection of genetic abnormalities causing genetic diseases, further fueling the market for growth.
According to WHO, about 39.0 million people were living with HIV at the end of 2022, including about 1.5 million children within the age group of 0 to 14 years. Seasonal influenza throughout the winter can infect up to 20% of the population and result in significant death. According to WHO data, respiratory illnesses associated with seasonal influenza causes up to 650,000 deaths globally each year.
Expanding Applications in Clinical Diagnosis and Genetic and Molecular Testing
PCR technology has several practical applications in the field of clinical diagnosis and in recent years, with increasing research and development, a significant expansion of PCR applications has been observed. PCR technology has been extensively utilized for COVID-19 diagnosis, driving demand in the market. Several notable applications of PCR technologies include broad-spectrum pathogen detection, assessment and surveillance of emerging infections, early detection of biological threat agents, and antimicrobial resistance analysis. Market players are coming up with innovative products for emerging applications of PCR technologies. In August 2022, GenScript USA Inc. launched a monkeypox virus PCR test kit, which was developed in partnership with Anbio Biotechnology. The kit was developed to address the monkeypox public health emergency in the United States.
Reagents and Consumables Segments are Expected to Dominate the Market
Reagents and consumables segments are expected to grow at a fast rate in the forecasted period. The instruments used for PCR tests are one-time investments while the reagents and consumables are repeatedly consumed and purchased, which drives major revenue. Reagents like primers, polymerase, nucleotides, reaction buffers, and consumables like well plates and pipette tips are consumed completely in each PCR process and need to be refilled for the next test, drawing reoccurring revenue in the market.
North America is Expected to Lead the PCR Technologies Market
North America dominates the global PCR market, with the United States and Canada holding largest market shares. The region's dominance is attributed to several factors, including extensive research infrastructure and a well-established regulatory framework that expedites approvals for new therapies. The presence of major pharmaceutical and biotechnology companies in the region has driven the development and adoption of PCR technologies. Additionally, North America has attracted significant investments in PCR research and development, enabling the establishment of state-of-the-art facilities and access to advanced technologies.
Report Scope
“Global PCR Technologies Market Assessment, Opportunities and Forecast, 2017-2031F”, is a comprehensive report by Markets and Data, providing in-depth analysis and qualitative and quantitative assessment of the current state of global PCR technologies market, industry dynamics, and challenges. The report includes market size, segmental shares, growth trends, COVID-19, opportunities, and forecast between 2024 and 2031F. Additionally, the report profiles the leading players in the industry mentioning their respective market share, business model, competitive intelligence, etc.
|
Report Attribute |
Details |
|
Base Year of the Analysis |
2023 |
|
Historical Period |
2017-2022 |
|
Forecast Period |
2024-2031F |
|
Projected Growth Rate |
CAGR of 8.89% between 2024 and 2031F |
|
Revenue Forecast in 2031 |
USD 29.75 billion |
|
Units |
Revenue in USD billion |
|
Segments Covered |
Product, Technology, Application, End-user |
|
Regions Covered |
North America, Europe, Asia-Pacific, Middle East, and Africa, South America |
|
Key Companies Profiled |
Abbott Laboratories, Agilent Technologies Inc., Becton, Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Merck KGaA, PerkinElmer Inc., Promega Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Danaher Corporation, QIAGEN, QuantuMDx Group Ltd, Eppendorf SE |
|
Customization Scope |
15% free report customization with purchase |
|
Pricing and Purchase Options |
Avail the customized purchase options to fulfil your precise research needs |
|
Delivery Format |
PDF and Excel through email (subject to the license purchased) |
In this report, global PCR technologies market has been segmented into the following categories:
· By Product
o Instruments
o Reagents
o Consumables
o Software and Services
o Others
o Conventional PCR
o qPCR (Real-Time PCR)
o dPCR (Digital PCR)
o Other PCR Technologies
· By Application
§ Genotyping
§ Sequencing
§ Gene Expression
§ Forensics
o Diagnostics Applications
o Others
· By End-user
o Diagnostic Centre
o Pharmaceutical and Biotechnology Companies
o Clinical Research Organizations
o Academia Laboratories
· By Region
o North America
o Europe
o Asia Pacific
o South America
o Middle East & Africa
Key Players Landscape and Outlook
The market landscape for PCR technologies is growing with several key players contributing to its development and commercialization. The key players in this market include Bio-Rad Laboratories Inc., Merck KGaA, QIAGEN and others. These companies are involved in various growth strategies, such as partnerships, agreements, collaborations, new product launches, geographical expansions, mergers, and acquisitions to enhance their presence.
In September 2023, Bio-Rad Laboratories, Inc. announced the launch of two new PCR instruments named PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers. PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers are a novel addition to Bio-Rad Laboratories’ portfolio of conventional PCR instruments. PTC Tempo 48/48 has the unique feature of two separate compartments with manual lids which allows two protocols to run simultaneously. The launch aims to support PCR applications in basic and translational research, process development, and quality control.
Key Players Operating in the Global PCR Technologies Market are:
· Abbott Laboratories
· Agilent Technologies Inc.
· Becton, Dickinson and Company
· BioMerieux SA
· Bio-Rad Laboratories Inc.
· Merck KGaA
· PerkinElmer Inc.
· Promega Corporation
· Siemens Healthineers AG
· Thermo Fisher Scientific Inc.
· Danaher Corporation
· QIAGEN GmbH
· QuantuMDx Group Ltd
· Eppendorf SE
Markets and Data reports answer the following questions:
· What is the current and future market size of the product/service in question globally or specific to different countries?
· How are the markets divided into different product/service segments and the market size and growth of each segment?
· What is the market potential of different product segments and their investment case?
· How are the markets predicted to develop in the future and what factors will drive or inhibit growth?
· What is the business environment and regulatory landscape specific to the product/service?
If you can't find what you're searching for or have any custom requirements for global PCR technologies market, you may approach our team at info@marketsandata.com.
Table of Contents
1. Research Methodology
2. Project Scope & Definitions
3. Executive Summary
4. Global PCR Technologies Market Outlook, 2017-2031F
5.1 Market Size & Forecast
4.1.1.By Value
4.1.2.By Volume
4.2. By Product
4.2.1.Instruments
4.2.2.Reagents
4.2.3.Consumables
4.2.4.Software and Services
4.2.5.Others
4.3. By Technology
4.3.1.Conventional PCR
4.3.2.qPCR (Real-Time PCR)
4.3.3.dPCR (Digital PCR)
4.3.4.Other PCR Technologies
4.4. By Application
4.4.1.Research Applications
4.4.1.1. Genotyping
4.4.1.2. Sequencing
4.4.1.3. Gene Expression
4.4.1.4. Forensics
4.4.2.Diagnostics Applications
4.4.3.Others
4.5. By End-user
4.5.1.Hospital
4.5.2.Diagnostic Centre
4.5.3.Pharmaceutical and Biotechnology Companies
4.5.4.Clinical Research Organizations
4.5.5.Academia Laboratories
4.6. By Region
4.6.1.North America
4.6.2.Europe
4.6.3.Asia Pacific
4.6.4.South America
4.6.5.Middle East & Africa
4.7. By Company Market Share (%), 2023
5. Global PCR Technologies Market Outlook, By Region, 2017-2031F
5.1. North America
5.1.1.Market Size & Forecast
5.1.1.1. By Value
5.1.1.2. By Volume
5.1.2.1. Instruments
5.1.2.2. Reagents
5.1.2.3. Consumables
5.1.2.4. Software and Services
5.1.2.5. Others
5.1.3.By Technology
5.1.3.1. Conventional PCR
5.1.3.2. qPCR (Real-Time PCR)
5.1.3.3. dPCR (Digital PCR)
5.1.3.4. Other PCR Technologies
5.1.4.By Application
5.1.4.1. Research Applications
5.1.4.1.1. Genotyping
5.1.4.1.2. Sequencing
5.1.4.1.3. Gene Expression
5.1.4.1.4. Forensics
5.1.4.2. Diagnostics Applications
5.1.4.3. Others
5.1.5.By End-user
5.1.5.1. Hospital
5.1.5.2. Diagnostic Centre
5.1.5.3. Pharmaceutical and Biotechnology Companies
5.1.5.4. Clinical Research Organizations
5.1.5.5. Academia Laboratories
5.1.6.United States*
5.1.6.1. Market Size & Forecast
5.1.6.1.1. By Value
5.1.6.1.2. By Volume
5.1.6.2. By Product
5.1.6.2.1. Instruments
5.1.6.2.2. Reagents
5.1.6.2.3. Consumables
5.1.6.2.4. Software and Services
5.1.6.2.5. Others
5.1.6.3. By Technology
5.1.6.3.1. Conventional PCR
5.1.6.3.2. qPCR (Real-Time PCR)
5.1.6.3.3. dPCR (Digital PCR)
5.1.6.3.4. Other PCR Technologies
5.1.6.4. By Application
5.1.6.4.1. Research Applications
5.1.6.4.1.1. Genotyping
5.1.6.4.1.2. Sequencing
5.1.6.4.1.3. Gene Expression
5.1.6.4.1.4. Forensics
5.1.6.4.2. Diagnostics Applications
5.1.6.4.3. Others
5.1.6.5. By End-user
5.1.6.5.1. Hospital
5.1.6.5.2. Diagnostic Centre
5.1.6.5.3. Pharmaceutical and Biotechnology Companies
5.1.6.5.4. Clinical Research Organizations
5.1.6.5.5. Academia Laboratories
5.1.7.Canada
5.1.8.Mexico
*All segments will be provided for all regions and countries covered
5.2. Europe
5.2.1.Germany
5.2.2.France
5.2.3.Italy
5.2.4.United Kingdom
5.2.5.Russia
5.2.6.Netherlands
5.2.7.Spain
5.2.8.Turkey
5.2.9.Poland
5.3. South America
5.3.1.Brazil
5.3.2.Argentina
5.4. Asia-Pacific
5.4.1.India
5.4.2.China
5.4.3.Japan
5.4.4.Australia
5.4.5.Vietnam
5.4.6.South Korea
5.4.7.Indonesia
5.4.8.Philippines
5.5. Middle East & Africa
5.5.1.Saudi Arabia
5.5.2.UAE
5.5.3.South Africa
6. Market Mapping, 2023
6.1. By Therapy
6.2. By Technology
6.3. By Application
6.4. By End-user
6.5. By Region
7. Macro Environment and Industry Structure
7.1. Supply Demand Analysis
7.2. Import Export Analysis – Volume and Value
7.3. Supply/Value Chain Analysis
7.4. PESTEL Analysis
7.4.1.Political Factors
7.4.2.Economic System
7.4.3.Social Implications
7.4.4.Technological Advancements
7.4.5.Environmental Impacts
7.4.6.Legal Compliances and Regulatory Policies (Statutory Bodies Included)
7.5. Porter’s Five Forces Analysis
7.5.1.Supplier Power
7.5.2.Buyer Power
7.5.3.Substitution Threat
7.5.4.Threat from New Entrant
7.5.5.Competitive Rivalry
8. Market Dynamics
8.1. Growth Drivers
8.2. Growth Inhibitors (Challenges, Restraints)
9. Regulatory Framework and Innovation
9.1. Clinical Trials
9.2. Patent Landscape
9.3. Regulatory Approvals
9.4. Innovations/Emerging Technologies
10. Key Players Landscape
10.1. Competition Matrix of Top Five Market Leaders
10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
10.4. SWOT Analysis (For Five Market Players)
10.5. Patent Analysis (If Applicable)
11. Pricing Analysis
12. Case Studies
13. Key Players Outlook
13.1. Abbott Laboratories
13.1.1. Company Details
13.1.2. Key Management Personnel
13.1.3. Products & Services
13.1.4. Financials (As reported)
13.1.5. Key Market Focus & Geographical Presence
13.1.6. Recent Developments
13.2. Agilent Technologies Inc.
13.3. Becton, Dickinson and Company
13.4. bioMerieux SA
13.5. Bio-Rad Laboratories Inc.
13.6. Merck KGaA
13.7. PerkinElmer Inc.
13.8. Promega Corporation
13.9. Siemens Healthcare
13.10. Thermo Fisher Scientific Inc.
13.11. Danaher Corporation
13.12. QIAGEN
13.13. QuantuMDx Group Ltd
13.14. Eppendorf
*Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work
14. Strategic Recommendations
15. About Us & Disclaimer
List of Figures
Figure 1. Global PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 2. Global PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 3. Global PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 4. Global PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 5. Global PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 6. Global PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 7. Global PCR Technologies Market Share (%), By Region, 2017-2031F
Figure 8. North America PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 9. North America PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 10. North America PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 11. North America PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 12. North America PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 13. North America PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 14. North America PCR Technologies Market Share (%), By Country, 2017-2031F
Figure 15. United States PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 16. United States PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 17. United States PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 18. United States PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 19. United States PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 20. United States PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 21. Canada PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 22. Canada PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 23. Canada PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 24. Canada PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 25. Canada PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 26. Canada PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 27. Mexico PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 28. Mexico PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 29. Mexico PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 30. Mexico PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 31. Mexico PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 32. Mexico PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 33. Europe PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 34. Europe PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 35. Europe PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 36. Europe PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 37. Europe PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 38. Europe PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 39. Europe PCR Technologies Market Share (%), By Country, 2017-2031F
Figure 40. Germany PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 41. Germany PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 42. Germany PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 43. Germany PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 44. Germany PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 45. Germany PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 46. France PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 47. France PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 48. France PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 49. France PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 50. France PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 51. France PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 52. Italy PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 53. Italy PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 54. Italy PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 55. Italy PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 56. Italy PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 57. Italy PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 58. United Kingdom PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 59. United Kingdom PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 60. United Kingdom PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 61. United Kingdom PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 62. United Kingdom PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 63. United Kingdom PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 64. Russia PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 65. Russia PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 66. Russia PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 67. Russia PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 68. Russia PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 69. Russia PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 70. Netherlands PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 71. Netherlands PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 72. Netherlands PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 73. Netherlands PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 74. Netherlands PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 75. Netherlands PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 76. Spain PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 77. Spain PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 78. Spain PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 79. Spain PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 80. Spain PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 81. Spain PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 82. Turkey PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 83. Turkey PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 84. Turkey PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 85. Turkey PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 86. Turkey PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 87. Turkey PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 88. Poland PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 89. Poland PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 90. Poland PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 91. Poland PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 92. Poland PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 93. Poland PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 94. South America PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 95. South America PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 96. South America PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 97. South America PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 98. South America PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 99. South America PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 100. South America PCR Technologies Market Share (%), By Country, 2017-2031F
Figure 101. Brazil PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 102. Brazil PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 103. Brazil PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 104. Brazil PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 105. Brazil PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 106. Brazil PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 107. Argentina PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 108. Argentina PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 109. Argentina PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 110. Argentina PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 111. Argentina PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 112. Argentina PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 113. Asia-Pacific PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 114. Asia-Pacific PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 115. Asia-Pacific PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 116. Asia-Pacific PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 117. Asia-Pacific PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 118. Asia-Pacific PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 119. Asia-Pacific PCR Technologies Market Share (%), By Country, 2017-2031F
Figure 120. India PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 121. India PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 122. India PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 123. India PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 124. India PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 125. India PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 126. China PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 127. China PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 128. China PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 129. China PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 130. China PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 131. China PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 132. Japan PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 133. Japan PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 134. Japan PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 135. Japan PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 136. Japan PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 137. Japan PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 138. Australia PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 139. Australia PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 140. Australia PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 141. Australia PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 142. Australia PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 143. Australia PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 144. Vietnam PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 145. Vietnam PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 146. Vietnam PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 147. Vietnam PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 148. Vietnam PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 149. Vietnam PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 150. South Korea PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 151. South Korea PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 152. South Korea PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 153. South Korea PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 154. South Korea PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 155. South Korea PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 156. Indonesia PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 157. Indonesia PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 158. Indonesia PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 159. Indonesia PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 160. Indonesia PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 161. Indonesia PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 162. Philippines PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 163. Philippines PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 164. Philippines PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 165. Philippines PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 166. Philippines PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 167. Philippines PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 168. Middle East & Africa PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 169. Middle East & Africa PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 170. Middle East & Africa PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 171. Middle East & Africa PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 172. Middle East & Africa PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 173. Middle East & Africa PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 174. Middle East & Africa PCR Technologies Market Share (%), By Country, 2017-2031F
Figure 175. Saudi Arabia PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 176. Saudi Arabia PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 177. Saudi Arabia PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 178. Saudi Arabia PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 179. Saudi Arabia PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 180. Saudi Arabia PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 181. UAE PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 182. UAE PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 183. UAE PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 184. UAE PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 185. UAE PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 186. UAE PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 187. South Africa PCR Technologies Market, By Value, In USD Billion, 2017-2031F
Figure 188. South Africa PCR Technologies Market, By Volume, In Millions, 2017-2031F
Figure 189. South Africa PCR Technologies Market Share (%), By Product, 2017-2031F
Figure 190. South Africa PCR Technologies Market Share (%), By Technology, 2017-2031F
Figure 191. South Africa PCR Technologies Market Share (%), By Application, 2017-2031F
Figure 192. South Africa PCR Technologies Market Share (%), By End-user, 2017-2031F
Figure 193. By Product Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 194. By Technology Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023
List of Tables
Table 1. Pricing Analysis of Products from Key Players
Table 2. Competition Matrix of Top 5 Market Leaders
Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
Table 4. About Us - Regions and Countries Where We Have Executed Client Projects
Frequently Asked Questions
What are the regions covered in the final report for global PCR technologies market?
Who are the key players operating in global PCR technologies market?
What are the major drivers influencing the growth of global PCR technologies market?
What is the market size and growth rate of global PCR technologies market?
See Related Reports
Global Coffee Market Assessment, Opportunities and Forecast, 2017-2031F
Global coffee market is expected to experience growth due to consumers’ increasing preference for organic and premium coffee that offers freshness, superior quality of beans and roasts, and unique flavor profile. Additionally, the product innovation,....Read More
Published on
July 2024
4,500
Global Home Theater System Market Assessment, Opportunities and Forecast, 2017-2031F
Global home theater system market is expected to experience growth due to technological advancements, increasing disposable incomes, rising demand for high-definition content, integration with smart home systems, and the surge in streaming services p....Read More
Published on
July 2024
4,500
Global Baby Food Market Assessment, Opportunities and Forecast, 2017-2031F
Global baby food market is expected to experience growth due to factors such as consumers’ increasing awareness of the nutrients which are essential for babies development and introduction of wide variety of baby foods in the market from milk powders....Read More
Published on
July 2024
4,500
Global Isoflavones Market Assessment, Opportunities and Forecast, 2017-2031F
Global isoflavones market is expected to experience growth due to increasing consumer health awareness, rising demand for functional foods and nutraceuticals, advancements in extraction technologies, and expanding applications in cosmetics, pharmaceu....Read More
Published on
July 2024
4,500
Purchase Options
USD ($)
i
3,000
i
4,500
i
5,700
i
8,200
Tired of Searching?
Looking for Customization?
Some other doubt?
Need insights from a cohort?
REACH US
